Vaccination Concerns, Issues, and Motivators

Data Summary

Surveys are conducted online using Ipsos KnowledgePanel and the NORC AmeriSpeak probability-based panels. Data are based on responses from adults 18 years and older regarding COVID-19, flu, and RSV vaccination concerns, issues, and motivators. Estimates are updated every 2 months. Updates to concerns and issues data alternate publishing months with the motivators data.

Concerns and Issues

• For February 2026, the most commonly reported vaccination concern or issue among adults 18 years and older was "possible serious or unknown side effects" for COVID-19 vaccine (30.6%) and "not concerned about getting the flu" for flu vaccine (19.4%). This was consistent across most demographic subgroups but varied by intent to get vaccinated.
• Among adults 50-74 years with high-risk condition(s) and adults 75 years and older, the most commonly reported concerns/issues about RSV vaccination were "do not know enough about RSV or the vaccine" (18.7%), "no provider recommendation" (16.5%), and “possible serious or unknown side effects” (15.7%). This was consistent across most demographic subgroups but varied by intent to get vaccinated.
• Many adults reported no concerns or issues about these vaccines (30.3% for COVID-19; 49.9% for flu; 48.8% for RSV).

Motivators

• For March 2026, the most commonly reported vaccination motivator among adults 18 years and older was "to protect myself" for COVID-19 (36.6%) and flu (42.7%) vaccines. This was largely consistent across demographic subgroups but varied by intent to get vaccinated.

• Among adults 50-74 years with high-risk condition(s) and adults 75 years and older, the most commonly reported motivator for RSV vaccination was "to protect myself" (50.0%). This was consistent across most demographic subgroups but varied by intent to get vaccinated.

• Some adults reported nothing would motivate them to get these vaccines (32.6% for COVID-19; 29.5% for flu; 22.5% for RSV).

Download Data